Oct 29 |
AbbVie’s Deal for Alzheimer’s Antibody Raises Curtain for Roche News on Wednesday
|
Oct 29 |
AbbVie to Acquire Aliada Therapeutics for $1.4 Billion, Expanding Alzheimer's Pipeline
|
Oct 29 |
AbbVie Q3 Earnings Preview: Modest guidance raise expected
|
Oct 29 |
AbbVie Chart Reflects Bearish Signals Ahead Of Q3 Earnings
|
Oct 29 |
Does AbbVie (NYSE:ABBV) Have A Healthy Balance Sheet?
|
Oct 29 |
SkinSpirit joins Allergan Aesthetics in Supporting Girls Inc. and Empowering the New Generation of Women in STEM
|
Oct 29 |
AbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in Ontario
|
Oct 29 |
Pfizer (PFE) Surpasses Q3 Earnings and Revenue Estimates
|
Oct 29 |
AbbVie signs agreement to acquire Aliada for $1.4bn
|
Oct 28 |
Analysts Believe These Dividend Aristocrats Are Primed For A Massive 2025-Get Them While They're Still Underpriced
|